0001014108-22-000043.txt : 20220214
0001014108-22-000043.hdr.sgml : 20220214
20220214153151
ACCESSION NUMBER: 0001014108-22-000043
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ugwumba Chidozie
CENTRAL INDEX KEY: 0001835544
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 22630577
MAIL ADDRESS:
STREET 1: 158 FILMORE STREET
CITY: DENVER
STATE: CO
ZIP: 80206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BiomX Inc.
CENTRAL INDEX KEY: 0001739174
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 EINSTEIN ST., 5TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
BUSINESS PHONE: (972) 72 394 2377
MAIL ADDRESS:
STREET 1: 22 EINSTEIN ST., 5TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20180430
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2021-12-31
0
0001739174
BiomX Inc.
PHGE
0001835544
Ugwumba Chidozie
609 SW 8TH STREET
SUITE 365
BENTONVILLE
AR
72712
0
0
1
0
Common Stock
3637846
I
By SymBiosis, LLC
Warrants to purchase Common Stock
5
2022-01-28
2027-01-28
Common Stock
1875000
I
By SymBiosis, LLC
The shares are directly held by SymBiosis, LLC. Previously, the beneficial owner of these shares was Thomas Layton Walton, by virtue of his sole voting power and dispositive power through SymBiosis, LLC. Although SymBiosis, LLC continues to hold these shares directly and Thomas Layton Walton continues to hold his pecuniary interest in these shares, the reporting person now exercises sole voting power and dispositive power through SymBiosis, LLC through a transition of that power to the reporting person (and not through a sale or other transfer of these shares).
These shares beneficially owned by the reporting person include (i) 1,137,846 shares of common stock already owned by SymBiosis, LLC prior to July 28, 2021, (ii) 2,500,000 shares of common stock owned by SymBiosis, LLC that were purchased in the registered direct offering by BiomX Inc. that closed on July 28, 2021 and (iii) warrants (to purchase 1,875,000 shares of common stock) owned by SymBiosis, LLC that were purchased in the registered direct offering by BiomX Inc. that closed on July 28, 2021.
/s/ Chidozie Ugsumba
2022-02-13